Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Applied BioCode, Inc. logo — The Ideal Choice for Cost-Effective High Throughput Syndromi...

Applied BioCode, Inc.

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Founded 2008 United States Santa Fe Springs, United States 60 employees Series Unknown Total: $17.51M Biotechnology, Health Care +1

General Information

Company Name Applied BioCode, Inc.
Founded Year 2008
Location United States Santa Fe Springs, United States +1
Founders / Decision Makers
Team member
Employees 60
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series Unknown
Social

Get notified when Applied BioCode, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Applied BioCode, Inc.

Applied BioCode, Inc. is a biotechnology company based in Los Angeles, California that focuses on the development, manufacturing, and commercialization of multiplex diagnostic testing products for in vitro diagnostics, research, and industrial applications. The company has pioneered the Barcoded Magnetic Beads (BMB) technology, combining digital barcodes with immunochemistry and molecular probes to enable the accurate identification of a high number of biological targets. Applied BioCode, Inc. targets the $4.5 billion molecular diagnostic infectious disease segment, offering assays for gastrointestinal infections, respiratory infections, and other high-value diseases. Founded in 2008, the company has achieved significant milestones in product development and regulatory clearances. It received FDA Clearance for the BioCode® MDx-3000 system, including the Gastrointestinal Pathogen Panel (GPP) and the Respiratory Pathogen Panel (RPP), as well as the CE-Mark for the GPP for use in European countries. Notably, in response to the COVID-19 pandemic, Applied BioCode, Inc. has developed the BioCode® SARS-CoV-2 Assay, authorized by the FDA under the Emergency Use Authorization (EUA). With its innovative technology and product portfolio, the company has attracted investment, including a $9.26M Venture Round investment in April 2016. Applied BioCode, Inc. has also established partnerships across various diagnostic and pharmaceutical applications, further indicating its potential for growth and impact within the biotechnology industry.

Taxonomy: Molecular Diagnostics, In Vitro Diagnostics, Multiplex Testing, Infectious Diseases, Syndromic Panels, Biomedical Technology, Clinical Diagnostics, Microbiology, Pathogen Detection, Diagnostic Testing, Bioassay Solutions, Immunoassay, Life Science Research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 08 Apr 2016
Venture Round •••••• - 06 Dec 2012
Venture Round •••••• - 26 Nov 2012

Applied BioCode, Inc. Alternatives & Competitors

Applied BioCode, Inc. vs
Mobidiag, A Hologic Company
Mobidiag, A Hologic Company Finland

Molecular diagnostics for infectious diseases and antibiotic resistance management.

Debt Financing
96 employees
Biotechnology, Health Care
Compare Applied BioCode, Inc. vs Mobidiag, A Hologic Company
Applied BioCode, Inc. vs
LGC Clinical Diagnostics
LGC Clinical Diagnostics United States

LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalog and custom-d...

202 employees
Biotechnology, Health Care

FAQ About Applied BioCode, Inc.

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels
Applied BioCode, Inc. was founded in 2008.
Applied BioCode, Inc. is headquartered in Santa Fe Springs, United States.
Applied BioCode, Inc. operates in the following industries: Biotechnology, Health Care, Life Sciences.
Applied BioCode, Inc. has approximately 60 employees.
Applied BioCode, Inc. has completed 3 funding rounds, raising a total of $17.51M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Applied BioCode, Inc. include Mobidiag, A Hologic Company, LGC Clinical Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Applied BioCode, Inc. and Mobidiag, A Hologic Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Applied BioCode, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy